CSBR:NASDAQ
Champions Oncology Inc
4,34 $
arrow_downward
-1,36%(-0,060) 1D
20 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,45 $
High
4,45 $
Low
4,34 $
Mkt. cap
60,41 մլն
Avg. vol.
6,97 հզր
Volume
8,94 հզր
52-wk high
8,31 $
52-wk low
4,34 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
Open
4,45 $
High
4,45 $
Low
4,34 $
Mkt. cap
60,41 մլն
Avg. vol.
6,97 հզր
Volume
8,94 հզր
52-wk high
8,31 $
52-wk low
4,34 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
News stories
From web sources and news partners
Traders Union
·
5 ժամ առաջ
VIX fear index hits highest level since April 2025 as S&P 500 plunges
The Loadstar
·
2 ժամ առաջ
CNBC: S&P 500 and Dow close in correction; Nasdaq erases 2026 gain as AI rout picks up steam
Trefis
·
3 ժամ առաջ
25 S&P 500 Stocks Just Made New 52-Week Lows
JournalArta
·
25 րոպե առաջ
S&P 500 Falls Into Correction as AI Worries Deepen
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersՀաքենսաք, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitechampionsoncology.com